Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The development of outpatient surgery has become a national priority, with the objective of an ambulatory surgery rate of around 50% in 2016, whereas this rate reached only 37.7% in 2010.
In the context of the management of primary hyperparathyroidism, there are two possible approaches. The first, which is commonly performed on an outpatient basis, consists in approaching only the pathological gland, if it was first identified by scintigraphy and ultrasound (which is the case in one patient in two), without exploring the others parathyroid glands.
The reference technique consists in exploring the 4 parathyroid sites by transverse cervicotomy. Although more invasive, it minimizes the risk of failure due to the lack of knowledge of multi-glandular forms of the disease (15 to 20%), whose preoperative diagnosis is difficult. This reference technique is poorly performed on an outpatient basis while it lends itself to this type of management because of the superficial character of the operative site, a short operating time, moderate postoperative pain, rapid return oral nutrition and exceptional and early serious complications (delay <24 h for cervical hematoma, <24 h for hypocalcemia and immediate diagnosis of recurrent palsy).
In this study, the investigators hypothesize that parathyroidectomy with 4-gland parathyroid exploration is feasible by ensuring patient safety. The investigators also believe that outpatient management will not lead to any difference after 3-month surgery, but will reduce hospitalization costs while increasing patient satisfaction with conventional care. To do so, the investigators carried out an observational cohort study of patients with an indication of parathyroidectomy wo will undergo outpatient management or conventional management (stay overnight in hospital) to inform all of these data.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| outpatient management of parathyroidectomy |
| ||
| conventional management of parathyroidectomy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| outpatient management of parathyroidectomy | Procedure | The patient is discharged from hospital the same day of the parathyroidectomy intervention instead of conventional management (stay overnight in hospital) |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of conversion or readmission to conventional hospitalization | The primary endpoint will be assessed for patients receiving outpatient management. Proportion of patients who could not discharged from hospital the same day of surgery as originally scheduled or being readmitted to conventional hospitalization within 8 days post operatively. | within 8 days postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative pain evaluated using visual analogue scale (VAS) | Pain will be evaluated using visual analogue scale (VAS) . VAS score ranges from 0 to 10. A high VAS score represents a high level of pain while a low VAS score represents a low level of pain. | at day 0 post operatively |
| Postoperative pain evaluated using visual analogue scale (VAS) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Major patients with primary hyperparathyroidism
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Pierre CATTAN, Pr | Contact | 0142499381 | +33 | pierre.cattan@aphp.fr |
| Matthieu RESCHE-RIGON, Pr | Contact | 0142499742 | +33 | matthieu.resche-rigon@univ-paris-diderot.fr |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D049950 | Hyperparathyroidism, Primary |
| ID | Term |
|---|---|
| D006961 | Hyperparathyroidism |
| D010279 | Parathyroid Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| conventional management of parathyroidectomy | Procedure | The patient stays overnight in hospital after intervention |
|
Pain will be evaluated using visual analogue scale (VAS) . VAS score ranges from 0 to 10. A high VAS score represents a high level of pain while a low VAS score represents a low level of pain. |
| at day 1 post operatively |
| Postoperative pain evaluated using visual analogue scale (VAS) | Pain will be evaluated using visual analogue scale (VAS) . VAS score ranges from 0 to 10. A high VAS score represents a high level of pain while a low VAS score represents a low level of pain. | at day 8 post operatively |
| Proportion of patients with breathing difficulty. | Dyspnea will be evaluated using the New York Heart Association (NYHA) Functional Classification. The stage of dyspnea is classified in four categories based on how much patients are limited during physical activity. Breathing difficulty will be defined by a stage of 3 on the NYHA scale. | at day 1 post operatively |
| Proportion of patients with breathing difficulty. | Dyspnea will be evaluated using the New York Heart Association (NYHA) Functional Classification. The stage of dyspnea is classified in four categories based on how much patients are limited during physical activity. Breathing difficulty will be defined by a stage of 3 on the NYHA scale. | at day 8 post operatively |
| Proportion of patients with compressive cervical hematoma | clinical evaluation based on the occurrence of a cervical collection that can obstruct the upper aero-digestive tract (NYHA scale dyspnea) | at day 0 post operatively |
| Proportion of patients with compressive cervical hematoma | clinical evaluation based on the occurrence of a cervical collection that can obstruct the upper aero-digestive tract (NYHA scale dyspnea) | at day 1 post operatively |
| Proportion of patients with compressive cervical hematoma | clinical evaluation based on the occurrence of a cervical collection that can obstruct the upper aero-digestive tract (NYHA scale dyspnea) | at day 8 post operatively |
| Proportion of patients with hypocalcemia | Hypocalcemia will be defined as calcemia lower than 2 mmol/L or 80 mg/L | at day 1 post operatively |
| Proportion of patients with hypocalcemia | Hypocalcemia will be defined as calcemia lower than 2 mmol/L or 80 mg/L | at 3 months post operatively |
| Proportion of patients with recurrent nerve paralysis | Clinical evaluation based on the occurrence of voice modification with swallowing disorder | at day 0 post operatively |
| Proportion of patients with recurrent nerve paralysis | Clinical evaluation based on the occurrence of voice modification with swallowing disorder | at day 1 post operatively |
| Proportion of patients with recurrent nerve paralysis | Clinical evaluation based on the occurrence of voice modification with swallowing disorder | at day 8 post operatively |
| Patients' satisfaction regarding his/her care evaluated using visual analogue scale (VAS) | Patients' satisfaction evaluated using visual analogue scale (VAS). VAS score ranges from 0 to 10. A high VAS score represents a high level of satisfaction while a low VAS score represents a low level of satisfaction. | at day 0 post operatively |
| Patients' satisfaction regarding his/her care evaluated using visual analogue scale (VAS) | Patients' satisfaction evaluated using visual analogue scale (VAS). VAS score ranges from 0 to 10. A high VAS score represents a high level of satisfaction while a low VAS score represents a low level of satisfaction. | at day 1 post operatively |
| Patients' satisfaction regarding his/her care evaluated using visual analogue scale (VAS) | Patients' satisfaction evaluated using visual analogue scale (VAS). VAS score ranges from 0 to 10. A high VAS score represents a high level of satisfaction while a low VAS score represents a low level of satisfaction. | at 3 months post operatively |
| Total cost of mode of care | Total cost of hospital surgery stay and hospital readmission at 3 months | at 3 months post operatively |